Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) CAO Andrea Carolan Speers Sells 1,131 Shares of Stock

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) CAO Andrea Carolan Speers sold 1,131 shares of the firm’s stock in a transaction that occurred on Wednesday, January 12th. The stock was sold at an average price of $15.67, for a total transaction of $17,722.77. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Andrea Carolan Speers also recently made the following trade(s):

  • On Monday, January 3rd, Andrea Carolan Speers sold 1,330 shares of Tabula Rasa HealthCare stock. The stock was sold at an average price of $15.67, for a total transaction of $20,841.10.

NASDAQ TRHC opened at $15.02 on Friday. Tabula Rasa HealthCare, Inc. has a 52 week low of $10.05 and a 52 week high of $69.31. The company has a quick ratio of 1.27, a current ratio of 1.35 and a debt-to-equity ratio of 5.15. The business’s fifty day simple moving average is $13.45 and its 200-day simple moving average is $27.21. The firm has a market cap of $386.30 million, a PE ratio of -3.90 and a beta of 1.05.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings results on Thursday, November 4th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.15. Tabula Rasa HealthCare had a negative return on equity of 44.56% and a negative net margin of 27.37%. The business had revenue of $86.60 million for the quarter, compared to analyst estimates of $88.54 million. During the same quarter in the previous year, the firm earned ($0.35) EPS. The company’s quarterly revenue was up 22.8% compared to the same quarter last year. Research analysts expect that Tabula Rasa HealthCare, Inc. will post -1.75 EPS for the current year.

A number of equities research analysts have recently commented on the stock. Royal Bank of Canada dropped their price objective on shares of Tabula Rasa HealthCare from $70.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday, November 8th. SVB Leerink dropped their price target on shares of Tabula Rasa HealthCare from $40.00 to $23.00 and set a “market perform” rating on the stock in a research note on Monday, November 8th. Benchmark dropped their price target on shares of Tabula Rasa HealthCare from $55.00 to $30.00 and set a “buy” rating on the stock in a research note on Tuesday, November 9th. Stifel Nicolaus dropped their price target on shares of Tabula Rasa HealthCare from $42.00 to $24.00 and set a “hold” rating on the stock in a research note on Friday, November 5th. Finally, Jefferies Financial Group assumed coverage on shares of Tabula Rasa HealthCare in a research note on Wednesday, December 1st. They issued a “hold” rating and a $13.00 price target on the stock. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Tabula Rasa HealthCare currently has an average rating of “Hold” and an average target price of $27.80.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Millennium Management LLC raised its holdings in shares of Tabula Rasa HealthCare by 217.6% during the 2nd quarter. Millennium Management LLC now owns 121,121 shares of the company’s stock worth $6,056,000 after acquiring an additional 82,983 shares during the period. Vontobel Holding Ltd. raised its holdings in Tabula Rasa HealthCare by 50.3% in the 3rd quarter. Vontobel Holding Ltd. now owns 81,927 shares of the company’s stock valued at $2,148,000 after buying an additional 27,405 shares during the period. Nisa Investment Advisors LLC acquired a new position in Tabula Rasa HealthCare in the 2nd quarter valued at about $85,000. Millrace Asset Group Inc. acquired a new position in Tabula Rasa HealthCare in the 2nd quarter valued at about $2,674,000. Finally, Grandeur Peak Global Advisors LLC grew its position in Tabula Rasa HealthCare by 134.7% in the 2nd quarter. Grandeur Peak Global Advisors LLC now owns 22,698 shares of the company’s stock valued at $1,135,000 after acquiring an additional 13,025 shares in the last quarter. Institutional investors and hedge funds own 85.31% of the company’s stock.

About Tabula Rasa HealthCare

Tabula Rasa Healthcare, Inc is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services.

Recommended Story: How to Invest in Growth Stocks

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.